Compare Abbott Laboratories (ABT) vs Advanced Micro Devices (AMD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Advanced Micro Devices — how do they compare? Abbott Laboratories trades at $95.66 (market cap $166.94B), while Advanced Micro Devices trades at $511.55 (market cap $841.57B). The key difference: Advanced Micro Devices is far larger — about 5× Abbott Laboratories's market cap, and Abbott Laboratories pays a 2.63% dividend while Advanced Micro Devices pays none. Which is the better fit depends on your goals.
| ABT | AMD | |
|---|---|---|
Market Cap | $166.94B | $841.57B |
Sector | Health | Technology |
52-Week High | $136.62 | $580.91 |
52-Week Low | $82.57 | $137.82 |
Enterprise Value | $193.69B | $833.09B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
AMD trades at $552.05, up 6.61% today and near its 52-week high, with strong technical momentum and bullish moving averages. The company reported robust Q1 2026 earnings of $1.37 EPS, beating expectations, and shows accelerating revenue growth to $34.64 billion in 2025 with net income surging to $4.34 billion. Analyst sentiment remains overwhelmingly positive with 71% buy ratings.
AMD's AI-driven growth trajectory presents significant upside potential, though premium valuations (P/E 184) and intense semiconductor competition pose risks. The stock's technical strength and fundamental momentum support continued bullish sentiment, but investors should monitor execution against high expectations and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Advanced Micro Devices
Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.
Read more on AMD →
